Senate Subcommittee Agrees To $25.5 Mil. Boost For Device Reviews
This article was originally published in The Pink Sheet Daily
Sen. Bennett (R-Utah) expresses “personal interest” in device program funding during markup as Senate subcommittee allocates $25.5 mil. increase for CDRH device review program in FY 2005 Ag/approps bill.
You may also be interested in...
The Institute’s Board on Health Sciences Policy is preparing a clinical trials registry for fall release.
Institute says independent safety board may not be appropriate for devices, but experiences learned from the drug safety board may apply.
The document, intended for industry reps, consumer associations and other stakeholders, explains how to secure a time slot for public portions of FDA meetings and “encourages” disclosure of financial relationships. The draft guidance is released shortly before the advisory committee on the safety of COX-2 inhibitors.